Lipid generation and signaling in ovarian cancer.
Xu
Yan
Y
Department of Obstetrics and Gynecology, Indiana University, 975 W. Walnut St., IB355A, Indianapolis, IN 46202, USA. xu2@iupui.com
Wang
Dongmei
D
Wang
Zeneng
Z
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D015687:Cell Hypoxia; D016503:Drug Delivery Systems; D005260:Female; D005544:Forecasting; D006801:Humans; D008246:Lysophospholipids / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000502:physiology*; D009097:Multienzyme Complexes / Q000502:physiology*; D009363:Neoplasm Proteins / Q000502:physiology; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D043264:Phosphodiesterase I / Q000502:physiology*; D054467:Phospholipases A2 / Q000502:physiology; D054510:Phospholipases A2, Cytosolic / Q000037:antagonists & inhibitors / Q000502:physiology; D010727:Phosphoric Diester Hydrolases; D011755:Pyrophosphatases / Q000502:physiology*; D049368:Receptors, Lysophosphatidic Acid / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology*; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000502:physiology; D000099189:Lysophospholipase D
D000970:Antineoplastic Agents; D008246:Lysophospholipids; D009097:Multienzyme Complexes; D009363:Neoplasm Proteins; D043264:Phosphodiesterase I; D054467:Phospholipases A2; D054510:Phospholipases A2, Cytosolic; D010727:Phosphoric Diester Hydrolases; D011755:Pyrophosphatases; D049368:Receptors, Lysophosphatidic Acid; D013110:Sphingosine; D000099189:Lysophospholipase D; C060506:sphingosine 1-phosphate; C032881:lysophosphatidic acid